[LGND] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
08-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 145.14%
YoY- -97.06%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 26,366 43,979 50,382 66,088 57,419 45,693 72,473 -49.13%
PBT 3,171 55,536 24,140 857 -636 -20,140 -7,026 -
Tax 881 11,922 38,674 453 259 -4,755 -2,058 -
NP 2,290 41,949 -14,534 404 -895 -15,385 -4,968 -
Tax Rate -27.78% -21.47% -160.21% -52.86% - - - -
Total Cost 24,076 2,030 64,916 65,684 58,314 61,078 77,441 -54.20%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin 8.69 95.38 -28.85 0.61 -1.56 -33.67 -6.85 -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS 0.13 2.46 -0.86 0.02 -0.05 -0.92 -0.30 -
EPS Diluted 0.13 2.33 -0.86 0.02 -0.05 -0.91 -0.30 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.